Background: Glioma is the most common primary intracranial tumor, accounting for the vast
majority of intracranial malignant tumors. Aberrant expression of RNA: 5-methylcytosine …

m6A RNA methylation regulators can regulate the growth, progression, and invasion of
glioma cell by regulating their target genes, which provides a reliable support for the m6A …

Glioma is a common intracranial tumor and is generally associated with poor prognosis.
Recently, numerous studies illustrated the importance of 5-methylcytosine (m5C) RNA …

Background Although aberrant expression of N6‐methyladenine (m6A) methylation‐related
genes contribute to tumorigenesis in many solid tumors, the prognostic value of the m6A …

N6-methyladenosine (m6A) RNA methylation, the most common form of mRNA modification
and regulated by the m6A RNA methylation regulators (“writers,”“erasers,” and “readers”) …

Glioma progression seriously correlates to the epigenetic context. This study aims to identify
glioma subtypes by clustering analysis of patients using the multi-omics data of N6 …

Gliomas are the most frequent primary malignant brain tumors of the central nervous system,
causing significant impairment and death. There is mounting evidence that N7 …

5-Methylcytosine (m5C) methylation is an important RNA modification pattern that can
participate in oncogenesis and progression of cancers by affecting RNA stability, expression …

Background: Gliomas are the most common and fatal malignant type of tumor of the central
nervous system. RNA post-transcriptional modifications, as a frontier and hotspot in the field …

Background: The prognosis of low-grade glioma (LGG) is different from that of other
intracranial tumors. Although many markers of LGG have been established, few are used in …